Author

Mahary Lalarizo Rakoto

Drexel UniversityORCID 0000-0002-0128-352XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Amirali AmirfallahiD· 1 shared Binh N. Ha· 1 shared Edward J. HartsoughiD· 1 shared Elizabeth A. Haglund· 1 shared Gabriele RomanoiD· 1 shared Hannah A. F. Hetrick· 1 shared Jennifer L. HopeiD· 1 shared Laura CortiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Amirali AmirfallahORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PSGL-1 blockade delays relapse to BRAF/MEK inhibition in cutaneous melanoma

Olivia S. El Naggar, Binh N. Ha, Mahary Lalarizo Rakoto, Laura Cort, Amirali Amirfallah, Elizabeth A. Haglund, Pedro Urquiza, Hannah A. F. Hetrick, Linda M. Bradley, Edward J. Hartsough, Jennifer L. Hope, Gabriele Romano

This study shows that blocking PSGL-1 with BRAF/MEK inhibition improves durable tumor control in melanoma by reprogramming CD8+ T cells to a memory-like state.

bioRxiv · Jul 7, 2026 · PreprintImmunology